ArticleBMC plant biology2026
Divergent pathogenic strategies of Fusarium species in Panax notoginseng and biocontrol by a Bacillus-Serratia consortium.
Article in BMC plant biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Fusarium-induced root rot severely constrains Panax notoginseng cultivation, yet the differential pathogenicity and ecological interactions among coexisting Fusarium species remain poorly understood. By isolating three pathogenic isolates—Fusarium oxysporum LP1 and F. solani LP2/LP3—we uncovered a distinct ecological trade-off: F. oxysporum exhibits higher niche occupancy, whereas F. solani demonstrates markedly greater virulence.To manage this disease, we engineered the Bacillus subtilis-Serratia marcescens synthetic microbial consortium (BS) comprising antagonistic strains XY-6 and XB-7. BS application significantly enhanced disease suppression (56%) compared with single-strain treatments (21%–25%). Mechanistic evaluations revealed a synergistic triple-mode of action: (i) direct pathogen inhibition via cell-free filtrates (38% reduction); (ii) activation of host systemic resistance, evidenced by substantially increased peroxidase (133%) and superoxide dismutase (173%) activities; and (iii) beneficial restructuring of the rhizosphere fungal community, characterized by Mortierellomycota enrichment, elevated α-diversity, and fortified microbial interaction networks.Collectively, this study illuminates the ecological trade-off between virulence and niche fitness among Fusarium species, and provides a robust, sustainable microbiome-engineering strategy for mitigating soil-borne diseases in medicinal crops.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.